epibiotech Community
PR Center

epibiotechPR Center

T&R Biofab, Epibiotech to co-develop stem cell therapy for hair loss

Press
Author
epibiotech
Date
2021-06-04 09:53
Views
50
T&R Biofab, a company specializing in 3D bioprinting, said Thursday that it has signed a deal with Epibiotech, a new drug candidate material developer, to co-develop hair loss treatment using induced pluripotent stem cells.

Article link : https://www.koreabiomed.com/news/articleView.html?idxno=11291